Net Income (Loss) Attributable to Parent in USD of Avidity Biosciences, Inc. from 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Avidity Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to Q3 2025.
  • Avidity Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$174M, a 117% decline year-over-year.
  • Avidity Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$550M, a 96% decline year-over-year.
  • Avidity Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$322M, a 51.9% decline from 2023.
  • Avidity Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$212M, a 22% decline from 2022.
  • Avidity Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$174M, a 47.4% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Avidity Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$550M -$174M -$94M -117% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 -$456M -$157M -$86.5M -122% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-10
Q1 2025 -$369M -$116M -$46.9M -68.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-10
Q4 2024 -$322M -$102M -$41.8M -69.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$280M -$80.4M -$28M -53.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 -$252M -$70.8M -$23.8M -50.5% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-10
Q1 2024 -$229M -$68.9M -$16.5M -31.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-10
Q4 2023 -$212M -$60.4M -$9.97M -19.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$202M -$52.4M -$8.76M -20.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$193M -$47M -$1.34M -2.92% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$192M -$52.4M -$18.2M -53% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$174M -$50.5M -$11.9M -31% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$162M -$43.6M -$14.3M -48.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$148M -$45.7M -$19.3M -73.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$128M -$34.2M -$10.4M -43.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$118M -$38.5M -$22.3M -137% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$95.7M -$29.3M -$17.8M -156% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$77.9M -$26.4M -$15.8M -150% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$62.1M -$23.8M -$17.8M -292% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$44.4M -$16.3M -$5.87M -56.5% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-15
Q3 2020 -$38.5M -$11.4M -$4.77M -71.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$33.7M -$10.6M -$5.44M -106% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$28.3M -$6.09M -$3.54M -139% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$24.7M -$10.4M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$6.67M Jul 1, 2019 Sep 30, 2019 10-K 2021-03-15
Q2 2019 -$5.12M Apr 1, 2019 Jun 30, 2019 10-K 2021-03-15
Q1 2019 -$2.55M Jan 1, 2019 Mar 31, 2019 10-K 2021-03-15

Avidity Biosciences, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$322M -$110M -51.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$212M -$38.2M -22% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$174M -$56M -47.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$118M -$73.7M -166% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$44.4M -$19.6M -79.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$24.7M -$13.5M -121% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$11.2M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.